REG - Venture Life Group - Result of AGM

Venture LifeAnnouncement

23/05/2018 12:30

RNS Number : 0531P
Venture Life Group PLC
23 May 2018
 


23 May 2018
Venture Life Group plc
 
("Venture Life" or "the Company")
 
Result of AGM
 
Venture Life (AIM: VLG), the international consumer self-care company focused on developing, manufacturing and commercialising products for the self-care market, announces that at its Annual General Meeting held earlier today, all resolutions were duly passed.
 
 
Enquiries
 




Venture Life Group PLC


+44 (0) 1344 742870




Jerry Randall, Chief Executive Officer








Adrian Crockett, Chief Financial Officer   




























Northland Capital Partners Limited (Nominated Adviser and Joint Broker)


+44 (0) 20 3861 6625




Matthew Johnson / Edward Hutton (Corporate Finance)








John Howes / Vadim Alexandre (Corporate Broking) 


















Turner Pope Investments (TPI) Ltd (Joint Broker)


+44 (0) 20 3621 4120




James Pope / Ben Turner




























Walbrook PR


venturelife@walbrookpr.com or + 44 (0) 20 7933 8780




Anna Dunphy /Paul McManus


+44 (0) 7876 741 001 / +44 (0) 7980 541 893


















 
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population.  The Group's product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women's intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners. 
Through its Development and Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGUOUARWWAVUAR